Neither of these cases address core patent law issues and so their outcome will have little impact on patent law practice.

The Court has indicated some interest in four additional cases — requesting the views of the Solicitor General in those cases:

RPX Corporation v. ChanBond LLC, No. 17-1686 (What level of injury-in-fact is required to appeal of a PTAB IPR final decision?)

Ariosa Diagnostics, Inc. v. Illumina, Inc., No. 18-109 (What is the prior art date for unclaimed disclosures in provisional filing?)

Texas Advanced Optoelectronic Solutions, Inc. v. Renesas Electronics America, Inc., fka Intersil Corporation, No. 18-600 (Is an “offer to sell” infringement as of the date of the offer or the date of the proposed sale?)

HP Inc., fka Hewlett-Packard Company v. Berkheimer, No. 18-415 (Should patent eligibility be treated as a pure question of law?)

These four are the most likely cases to be heard by the court. However, the Solicitor General often takes a full-year to file a brief — meaning that the certiorari question may well be pending until the September 2019.

One additional case can be seen as a follow-on to the RPX standing-to-appeal question:

JTEKT Corporation v. GKN Automotive Ltd., No. 18-750 (direct competitor but no injury-in-fact sufficient to provide appellate jurisdiction)

Note here that JTEKT adds the nuance of being a direct competitor while RPX is ostensibly not a competitor.

In addition to the standing question, several pending petitions also address the scope and review of time-bar decisions under Section 315(b)(“An inter partes review may not be instituted if the petition requesting the proceeding is filed more than 1 year after the date on which the petitioner, real party in interest, or privy of the petitioner is served with a complaint alleging infringement of the patent.”)